Breast Cancer

Tests provide little to no benefit and can increase a breast cancer patient’s financial burden.

Top news of the day from across the health care landscape.

Collaboration between Novartis and IBM Watson Health integrates real-world data and analytical techniques on breast cancer outcomes.

Noavrtis teams with IBM Watson supercomputer to advance insights into breast cancer treatment.

Up to 50% of patients with HER2-positive breast cancer treated with targeted therapies develop brain metastases.

Scientists found that some breast cancer patients have a co-occurrence of genetic mutations.

While incidences of metastatic breast cancer are increasing, so is survival.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.

Imaging technology highlights cancerous features of a breast tumor.

Reducing overall body fat associated with lower levels of breast cancer markers.

Tumor biology may differ when cancer recurs.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Nanoparticle vaccines can travel directly to the lymph nodes to activate tumor-specific immune responses.

Imatinib found to reduce measures of airway inflammation in severe asthma.

Top articles of the week from The American Journal of Pharmacy Benefits.

Top news of the week in oncology and cancer drug development.

Top news of the day from across the health care landscape.

Breast cancer incidence has climbed among Asian Americans, while diagnosis rates among other groups have trended downward.

Substantial increase in breast cancer incidences among Koreans, South Asians, and Southeast Asians.

Oral cancer treatments provide new opportunities for improved overall survival rates, but patients are increasingly responsible for higher out-of-pocket costs as they self-manage their therapy.

Legendary NBA star Kareem-Abdul Jabbar faced his toughest battle after being diagnosed with Philadelphia chromosome-positive chronic myeloid leukemia.

Specialty pharmacists are uniquely positioned to help with the treatment of breast cancer.

With the rise of oral oncolytics, the ability to educate patients while providing resources to monitor compliance and adverse-effect management becomes even more critical. 

The final days of the Obama administration witnessed the federal government launch several initiatives seeking to advance the battle against cancer.